Chip Stocks Rally as AMD Tops $1T Amid US-China Trade Talks

US equity benchmarks posted gains Monday as investors positioned for a diplomatic breakthrough between Washington and Beijing. The technology-heavy Nasdaq Composite climbed 2% to close at 27,044.3, while the S&P 500 rose 1.4% to 7,755.5. The Dow Jones Industrial Average added 0.7% to reach 52,034.3. This intraday strength followed a mixed close on Friday, where the Nasdaq and S&P 500 had advanced while the Dow had fallen.

The rally was driven primarily by the semiconductor sector, which outperformed all other categories except for energy, which remained in negative territory. Communication services led the broader market advance. According to reporting from Yahoo! Finance Canada, the surge in tech stocks coincided with confirmed preliminary discussions between US Treasury Secretary Scott Bessent and Chinese Vice Premier He Lifeng. These talks, focused on artificial intelligence and trade, set the stage for an expected meeting between President Donald Trump and Chinese leader Xi Jinping later in the week.

AMD Market Value Crosses Milestone

Advanced Micro Devices (AMD) became the first company in the group to see its market capitalization exceed the $1 trillion threshold. Intel (INTC) recorded the largest percentage gain among S&P 500 constituents, climbing nearly 12% during the session. Qualcomm (QCOM) also posted significant gains, reinforcing the broad-based strength in chipmaking equities.

Nvidia (NVDA) contributed to the Dow’s performance with a 2.2% increase, marking its largest single-day gain on the index. The movement reflects investor expectations that easing tensions in US-China trade relations could reduce regulatory risks for semiconductor supply chains. The sector’s performance stood out against a backdrop of mixed Treasury yields, where the 10-year note edged down to 4.96%.

Novo Nordisk Shares Decline on Guidance

In contrast to the tech sector, Novo Nordisk (NVO) experienced a sharp 8.1% drop in its US-listed shares. The decline followed the company’s announcement of long-term growth strategies ahead of the expiration of patents for semaglutide. This active ingredient is central to the firm’s flagship weight-loss and diabetes treatments, and investors appeared concerned about the impact of upcoming generic competition on future revenue streams.

The pharmaceutical sector’s weakness highlighted a divergence in market sentiment, where growth stocks in technology benefited from geopolitical optimism while healthcare names faced fundamental headwinds. This move underscored the varying sensitivity of different sectors to macroeconomic and regulatory news flows during the trading session.

Commodity Prices Reflect Macroeconomic Shifts

Energy markets saw significant declines, with West Texas Intermediate crude oil falling 5.6% to $94.72 per barrel. Brent crude dropped 4.2% to $99.44. Safe-haven assets also retreated, as spot gold slipped 0.8% to $4,343.04 per troy ounce and silver lost 0.9% to $66.57. These moves suggest a reduction in risk aversion among investors as equity markets stabilized.

Chicago Fed President Austan Goolsbee commented on the economic environment, stating that policymakers can no longer ignore recurring supply shocks. He emphasized the need for evidence that these disruptions are fading to justify a credible path back to 2% inflation. This remark provides context for the current yield environment, where the two-year Treasury yield remained stable at 4.74%.